Skip to content

CP382 - Intermittent Catheter (IC) PRO Panel Plan

CP382 - Intermittent Catheter (IC) PRO Panel Plan

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07475468
Acronym
382 PRO Panel
Enrollment
1000
Registered
2026-03-16
Start date
2026-06-01
Completion date
2032-10-31
Last updated
2026-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intermittent Catheterization

Brief summary

The aim is to create an electronic patient reported outcome (e-PRO) based registry, specifically for subjects using an intermittent catheter as their primary bladder emptying method.

Detailed description

The registry's objective is to allow for insights into the needs of people with intimate healthcare needs from the user's perspective and experience. The registry will provide valuable information from the participants' perspective on several issues including, but not limited to product use and satisfaction, frequency of urinary tract infections, and quality-of-life related to IC use. The registry will allow for a more user-centric approach when listening and responding to the needs and challenges of IC users.

Interventions

OTHERNo Intervention: Observational Cohort

There is only one observational cohort.

Sponsors

Coloplast A/S
Lead SponsorINDUSTRY
IQVIA Pty Ltd
CollaboratorINDUSTRY

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Willing to give informed consent * 18 years of age or above * Full legal capacity * Willing and able (self-assessed) to complete online questionnaires * using intermittent catheterization as the primary method for bladder emptying

Design outcomes

Primary

MeasureTime frameDescription
Number of IC products used by subjects.5 yearsCharacterization of a cohort of IC users at point-of-entry to the registry including but not limited to, IC product consumption, user-patterns, prescriptions, and use of supporting products.
The number of urinary tract infections5 yearsFrequency and consequences of urinary tract infections.
The Mental well-being index (WHO-5)5 yearsQuality-of-life (QoL) using the Mental well-being index (WHO-5). The subject has 5 questions asked, with 6 different responses available: "All of the time", "Most of the time", "More than half the time", "less than half the time", "some of the time", and "at no time". The choice of "all of the time" equates to a better well-being than a response of "at no time".

Contacts

CONTACTCarri Browne. Clinical Project Manager, BS
dkcarr@coloplast.com6123235772
CONTACTAnn-Sophie luel-Brockdorff, Sr. Clinical Strategy Project Manager, PhD
dkasib@coloplast.com+45 49112078
STUDY_DIRECTORAnn-Sophie Luel-Brockdorff, PhD

Coloplast A/S

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 14, 2026